← All Interpace Biosciences, INC filings

Interpace Biosciences, INC Schedule 13G passive stakes

Filed when an investor crosses five percent without intending to seek control — the passive counterpart to a 13D.

OID
IDXG
Interpace Biosciences, INC
SCHEDULE 13G/A: Douglas M. Singer Discloses 4.44% Passive Stake in Interpace Biosciences, Inc.
Douglas M. Singer has filed an Amendment No. 4 to Schedule 13G, disclosing a beneficial ownership of 4.44% of Interpace Biosciences, Inc.'s common stock.
OID
IDXG
Interpace Biosciences, INC
SCHEDULE 13G/A: Douglas M. Singer Discloses 5.15% Stake in Interpace Biosciences, Inc.
Douglas M. Singer has filed an amended Schedule 13G, reporting beneficial ownership of 5.15% of Interpace Biosciences, Inc.'s common stock as of December 31, 2024.